Importer of Controlled Substances; Notice of Registration, 54069-54070 [E7-18704]
Download as PDF
Federal Register / Vol. 72, No. 183 / Friday, September 21, 2007 / Notices
Authority: The authority for institution of
this investigation is contained in section 337
of the Tariff Act of 1930, as amended, and
in section 210.10 of the Commission’s Rules
of Practice and Procedure, 19 CFR 210.10
(2007).
obtained by request at the above
address. Electronic copies may also be
obtained from the USIBWC Home Page
at https://www.ibwc.state.gov.
Dated: September 17, 2007.
Susan Daniel,
General Counsel.
[FR Doc. E7–18636 Filed 9–20–07; 8:45 am]
BILLING CODE 7010–01–P
INTERNATIONAL TRADE
COMMISSION
[Inv. No. 337–TA–614]
In the Matter of Certain Wireless
Communication Chips and Chipsets,
and Products Containing Same,
Including Wireless Handsets and
Network Interface Cards; Notice of
Investigation
U.S. International Trade
Commission.
ACTION: Institution of investigation
pursuant to 19 U.S.C. 1337.
mstockstill on PROD1PC66 with NOTICES
AGENCY:
SUMMARY: Notice is hereby given that a
complaint was filed with the U.S.
International Trade Commission on
August 16, 2007, under section 337 of
the Tariff Act of 1930, as amended, 19
U.S.C. 1337, on behalf of Nokia
Corporation of Finland and Nokia Inc.
of Irving, Texas. A supplement to the
complaint was filed on September 12,
2007. The complaint alleges violations
of section 337 in the importation into
the United States, the sale for
importation, and the sale within the
United States after importation of
certain wireless communication chips
and chipsets, and products containing
same, including wireless handsets and
network interface cards, by reason of
infringement of certain claims of U.S.
Patent Nos. 7,236,761, 6,714,091,
6,292,474, 5,896,562, and 5,752,172.
The complaint further alleges that an
industry in the United States exists as
required by subsection (a)(2) of section
337.
The complainants request that the
Commission institute an investigation
and, after the investigation, issue a
permanent exclusion order and
permanent cease and desist orders.
ADDRESSES: The complaint, except for
any confidential information contained
therein, is available for inspection
during official business hours (8:45 a.m.
to 5:15 p.m.) in the Office of the
Secretary, U.S. International Trade
Commission, 500 E Street, SW., Room
112, Washington, DC 20436, telephone
202–205–2000. Hearing impaired
individuals are advised that information
on this matter can be obtained by
VerDate Aug<31>2005
18:17 Sep 20, 2007
Jkt 211001
54069
Scope of Investigation: Having
considered the complaint, the U.S.
International Trade Commission, on
September 14, 2007, ordered that—
(1) Pursuant to subsection (b) of
section 337 of the Tariff Act of 1930, as
amended, an investigation be instituted
to determine whether there is a
violation of subsection (a)(1)(B) of
section 337 in the importation into the
United States, the sale for importation,
or the sale within the United States after
importation of certain wireless
communications chips or chipsets, or
products containing same, including
wireless handsets or network interface
cards, by reason of infringement of one
or more of claims 1–17, 19–20, and 22–
108 of U.S. Patent No. 7,236,761; claims
1–13 of U.S. Patent No. 6,714,091;
claims 1, 15, and 16 of U.S. Patent No.
6,292,474; claims 1–4, 7, and 11 of U.S.
Patent No. 5,896,562; and claims 1–3, 6,
8, and 14 of U.S. Patent No. 5,752,172,
and whether an industry in the United
States exists as required by subsection
(a)(2) of section 337;
(2) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainants are—
Nokia Corporation, Keilalahdentie 4,
P.O. Box 226, FIN–00045 Nokia
Group, Espoo, Finland.
Nokia Inc., 6000 Connection Drive,
Irving, Texas 75039.
(b) The respondent is the following
entity alleged to be in violation of
section 337, and is the party upon
which the complaint is to be served:
QUALCOMM, Inc., 5775 Morehouse
Drive, San Diego, California 92121.
(c) The Commission investigative
attorney, party to this investigation, is
David O. Lloyd, Esq., Office of Unfair
Import Investigations, U.S. International
Trade Commission, 500 E Street, SW.,
Suite 401, Washington, DC 20436; and
(3) For the investigation so instituted,
the Honorable Paul J. Luckern is
designated as the presiding
administrative law judge.
Responses to the complaint and the
notice of investigation must be
submitted by the named respondent in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(d) and 210.13(a), such
responses will be considered by the
Commission if received not later than 20
days after the date of service by the
Commission of the complaint and the
notice of investigation. Extensions of
time for submitting responses to the
complaint and the notice of
investigation will not be granted unless
good cause therefor is shown.
Failure of the respondent to file a
timely response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: September 17, 2007.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. E7–18674 Filed 9–20–07; 8:45 am]
contacting the Commission’s TDD
terminal on 202–205–1810. Persons
with mobility impairments who will
need special assistance in gaining access
to the Commission should contact the
Office of the Secretary at 202–205–2000.
General information concerning the
Commission may also be obtained by
accessing its Internet server at https://
www.usitc.gov. The public record for
this investigation may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov.
FOR FURTHER INFORMATION CONTACT:
David O. Lloyd, Esq., Office of Unfair
Import Investigations, U.S. International
Trade Commission, telephone (202)
205–2576.
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated June 26, 2007 and
published in the Federal Register on
July 3, 2007, (72 FR 36482–36483),
Lipomed, Inc., One Broadway,
Cambridge, Massachusetts 02142, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the basic
classes of controlled substances listed in
schedule I and II:
E:\FR\FM\21SEN1.SGM
21SEN1
54070
Federal Register / Vol. 72, No. 183 / Friday, September 21, 2007 / Notices
mstockstill on PROD1PC66 with NOTICES
Drug
Schedule
Cathinone (1235) ..........................
Methcathinone (1237) ..................
N-Ethylamphetamine (1475) ........
Methaqualone (2565) ...................
Gamma-Hydroxybutyric
Acid
(2010).
Lysergic acid diethylamide (7315)
2,5-Dimethoxy-4-(n)propylthiophenethylamine
(7348).
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Mescaline (7381) ..........................
3,4,5-Trimethoxyamphetamine
(7390).
4-Bromo-2–5dimethoxyamphetamine (7391).
4-Bromo-2,5dimethoxyphyenethylamine
(7392).
4-Methyl-2,5dimethoxyamphetamine (7395).
2,5-Dimethoxyamphetamine
(7396).
2,5-Dimethoxy-4ethylamphetamine (7399).
3,4-Methylenedioxyamphetamine
(7400).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4Methylenedioxymethamphetamine (7405).
4-Methoxyamphetamine (7411) ...
Dimethyltryptamine (7435) ...........
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
Acetyldihydrocodeine (9051) ........
Dihydromorphine (9145) ...............
Heroin (9200) ...............................
Normorphine (9313) .....................
Pholcodine (9314) ........................
Tilidine (9750) ...............................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Phencyclidine (7471) ....................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Benzoylecgonine (9180) ...............
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Levorphanol (9220) ......................
Meperidine (9230) ........................
Methadone (9250) ........................
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
Alfentanil (9737) ...........................
Fentanyl (9801) ............................
Sufentanil (9740) ..........................
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Dated: September 17, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–18704 Filed 9–20–07; 8:45 am]
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
II
II
II
II
II
II
The company plans to import
analytical reference standards for
distribution to its customers for research
and analytical purposes.
VerDate Aug<31>2005
18:17 Sep 20, 2007
Jkt 211001
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and § 952(a)
and determined that the registration of
Lipomed, Inc. to import the basic
classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated
Lipomed, Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and § 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
By Notice dated July 24, 2007 and
published in the Federal Register on
July 30, 2007, (72 FR 41527), Wildlife
Laboratories, 1401 Duff Drive, Suite 400,
Fort Collins, Colorado 80524, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of
Etorphine Hydrochloride (9059), a basic
class of controlled substance listed in
schedule II.
The company plans to import the
listed controlled substance for sale to its
customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Wildlife Laboratories to import the basic
classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated Wildlife
Laboratories to ensure that the
company’s registration is consistent
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: September 17, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–18676 Filed 9–20–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 04–58]
RX Direct Pharmacy, Inc.; Dismissal of
Proceeding
On May 17, 2004, I, the Deputy
Administrator of the Drug Enforcement
Administration, issued an Order to
Show Cause and further ordered the
immediate suspension of DEA
Certificate of Registration, BR8263876,
issued to RX Direct Pharmacy, Inc.
(Respondent) of Deerfield Beach,
Florida. The Order of Immediate
Suspension was based on my
preliminary finding that Respondent,
‘‘through its Internet service[,] has been
responsible for the diversion of large
quantities of controlled substances,’’ Id.
at 9, and that its continued registration
during the pendency of the proceeding,
‘‘would constitute an imminent danger
to the public health and safety because
of the substantial likelihood that [it
would] continue to divert controlled
substances.’’ Id. at 10.
The Show Cause Order proposed the
revocation of Respondent’s registration
as a retail pharmacy and to deny any
pending applications for renewal or
modification of the registration on the
ground that Respondent’s continued
registration would be inconsistent with
the public interest. Show Cause Order at
1 (citing 21 U.S.C. 823(f) & 824(a)). More
specifically, the Show Cause Order
alleged that Respondent’s customers
would access an affiliated Web site, at
which they would complete an on-line
questionnaire and list what drugs they
were seeking. Id. at 5. According to the
Show Cause Order, the questionnaires
were then submitted to ‘‘affiliated
physicians,’’ who would review the
E:\FR\FM\21SEN1.SGM
21SEN1
Agencies
[Federal Register Volume 72, Number 183 (Friday, September 21, 2007)]
[Notices]
[Pages 54069-54070]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-18704]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated June 26, 2007 and published in the Federal Register
on July 3, 2007, (72 FR 36482-36483), Lipomed, Inc., One Broadway,
Cambridge, Massachusetts 02142, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as an importer of the
basic classes of controlled substances listed in schedule I and II:
[[Page 54070]]
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)........................... I
Methcathinone (1237)....................... I
N-Ethylamphetamine (1475).................. I
Methaqualone (2565)........................ I
Gamma-Hydroxybutyric Acid (2010)........... I
Lysergic acid diethylamide (7315).......... I
2,5-Dimethoxy-4-(n)- I
propylthiophenethylamine (7348).
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
Mescaline (7381)........................... I
3,4,5-Trimethoxyamphetamine (7390)......... I
4-Bromo-2-5-dimethoxyamphetamine (7391).... I
4-Bromo-2,5-dimethoxyphyenethylamine (7392) I
4-Methyl-2,5-dimethoxyamphetamine (7395)... I
2,5-Dimethoxyamphetamine (7396)............ I
2,5-Dimethoxy-4-ethylamphetamine (7399).... I
3,4-Methylenedioxyamphetamine (7400)....... I
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3,4-Methylenedioxymethamphetamine (7405)... I
4-Methoxyamphetamine (7411)................ I
Dimethyltryptamine (7435).................. I
Psilocybin (7437).......................... I
Psilocyn (7438)............................ I
Acetyldihydrocodeine (9051)................ I
Dihydromorphine (9145)..................... I
Heroin (9200).............................. I
Normorphine (9313)......................... I
Pholcodine (9314).......................... I
Tilidine (9750)............................ I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Amobarbital (2125)......................... II
Pentobarbital (2270)....................... II
Secobarbital (2315)........................ II
Phencyclidine (7471)....................... II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Benzoylecgonine (9180)..................... II
Ethylmorphine (9190)....................... II
Hydrocodone (9193)......................... II
Levorphanol (9220)......................... II
Meperidine (9230).......................... II
Methadone (9250)........................... II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300)............................ II
Thebaine (9333)............................ II
Oxymorphone (9652)......................... II
Alfentanil (9737).......................... II
Fentanyl (9801)............................ II
Sufentanil (9740).......................... II
------------------------------------------------------------------------
The company plans to import analytical reference standards for
distribution to its customers for research and analytical purposes.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and Sec. 952(a) and determined that
the registration of Lipomed, Inc. to import the basic classes of
controlled substances is consistent with the public interest and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971, at this time. DEA has investigated
Lipomed, Inc. to ensure that the company's registration is consistent
with the public interest. The investigation has included inspection and
testing of the company's physical security systems, verification of the
company's compliance with state and local laws, and a review of the
company's background and history. Therefore, pursuant to 21 U.S.C.
952(a) and Sec. 958(a), and in accordance with 21 CFR 1301.34, the
above named company is granted registration as an importer of the basic
classes of controlled substances listed.
Dated: September 17, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-18704 Filed 9-20-07; 8:45 am]
BILLING CODE 4410-09-P